Cefaclor Capsules (Cefaclor Hydrate)
Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hyphil Life Science Co., Ltd.
MFDS item code 201903579 · Approved 2019.05.30
This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of otitis media, respiratory and urinary tract infections
This drug is effective against various bacteria including Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Escherichia coli. It is used for respiratory infections such as otitis media, pneumonia, pharyngitis, tonsillitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. It is utilized for treating skin and soft tissue infections, boils, carbuncles, folliculitis, cellulitis, infectious granulomas, subcutaneous abscesses, burn wounds, and wound infections. This drug is used for treating various infections caused by multiple bacteria, thereby improving infections.
As cefaclor hydrate, take 250 mg (potency) orally every 8 hours. In severe infections (such as pneumonia) and infections with low sensitivity, the dose may be doubled. For acute gonococcal urethritis, this drug 3g and probenecid 1g should be administered together in a single dose.
Administer 20 mg/kg (potency) divided every 8 hours. In cases of severe infections, otitis media, and infections with low sensitivity, administer 40 mg/kg (potency) daily, with a maximum dose of
This drug is an antibiotic that kills bacteria by binding to specific proteins, interfering with the synthesis of bacterial cell walls. It should not be used in patients who have previously experienced severe allergic reactions or shock due to this drug. Those with allergies to this drug or similar class antibiotics should also avoid it. Patients allergic to penicillin-class drugs or those prone to allergic reactions such as asthma, rashes, or hives must be more cautious when using this drug. Patients with severely impaired kidney function, those who have difficulty swallowing, elderly patients, and those in poor general condition should be carefully monitored for the risk of bleeding due to vitamin K deficiency. Patients with a history of gastrointestinal diseases, especially colitis, should also use this drug with caution. Rarely, this drug can cause shock or severe allergic reactions; if symptoms occur while using it, one should immediately stop taking the drug and seek appropriate treatment. Severe skin reactions such as Stevens-Johnson syndrome, characterized by severe rashes or blisters, can also occur, so caution is advised. Adverse effects such as blood abnormalities, liver function abnormalities, and renal impairment may occur, necessitating regular testing. Gastrointestinal symptoms, including abdominal pain, diarrhea, nausea, and vomiting, may occur, and severe colitis can develop, so consultation with medical personnel is needed if symptoms arise. Respiratory symptoms may include fever, cough, and difficulty breathing, and if these symptoms appear, the drug should be discontinued and treatment should be sought. The central nervous system may be affected, leading to dizziness, anxiety, insomnia, and hallucinations, which may occur rarely. Taking this drug may lead to disruptions in the oral flora, causing oral inflammation or candidiasis. Deficiency symptoms of vitamin K and B group may appear rarely; hence, one should be cautious in the presence of bleeding tendencies or neurological symptoms. This drug may interact with other medications, particularly those affecting the kidneys, anticoagulants, and oral contraceptives, so consultation with a physician is necessary when co-administering. Women who are pregnant or breastfeeding should use this drug cautiously, as its safety has not been fully established. It is advisable to avoid using this drug in newborns under 1 month of age, as its safety and efficacy have not been established. Elderly patients may experience more pronounced side effects due to decreased bodily functions; thus, dosage adjustment and monitoring of their condition are essential. Finally, when using this drug, it is crucial to verify the sensitivity of the infection-causing bacteria to prevent the occurrence of resistant strains and to administer the drug for the necessary minimum duration.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to avoid exposure to air or moisture. It is best stored at room temperature between 1°C and 30°C. This will help maintain the drug's efficacy.
A hard capsule with a purple upper part and a white lower part filled with pale yellow powder
30 capsules/bottle, 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hyphil Life Science Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.